Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_assertion type Assertion NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_head.
- NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_assertion description "[The finding that integrin alpha(v)beta1 is involved in Ad5 infection has implications for the use of recombinant Ad5 vectors for cancer gene therapy, since alpha(v)beta1 is expressed at high levels and acts as an alternative vitronectin receptor in many epithelial and some melanoma tumours which express no alpha(v)beta3 and constant low levels of alpha(v)beta5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_provenance.
- NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_assertion evidence source_evidence_literature NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_provenance.
- NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_assertion SIO_000772 11778901 NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_provenance.
- NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_assertion wasDerivedFrom befree-20150227 NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_provenance.
- NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_assertion wasGeneratedBy ECO_0000203 NP517339.RASsFWJh7CdrMxVmd_8mqhxBrFH1jzj1wwzU6OOEjmnx0130_provenance.